 Ketamine is gaining ground as a potential treating depression because it has a distinct mode of action than typical drugs that influence monoamine neurotransmitters including noradrenaline dopamine or serotonin . Ketamine is thought to act by blocking N methyl

@highlight Ketamine is thought to act by blocking N methyl 
@highlight  aspartate NMDA receptors in the brain.
@highlight Ketamine is an arylcycloalkylamine that is structurally related to phencyclidine PCP .
@highlight This review exploring the molecular targets for the treatment and psychomimetic phenomena of the ketamine.
